Altria Group (MO)
(Delayed Data from NYSE)
$49.42 USD
+0.30 (0.61%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $49.42 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$49.42 USD
+0.30 (0.61%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $49.42 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Top Research Reports for Novo Nordisk, QUALCOMM & Caterpillar
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk (NVO), QUALCOMM (QCOM) and Caterpillar (CAT), as well as two micro-cap stocks CSP Inc. (CSPI) and Epsilon Energy Ltd. (EPSN).
Zacks Industry Outlook Philip Morris, Altria and British American Tobacco
by Zacks Equity Research
Philip Morris, Altria and British American Tobacco have been highlighted in this Industry Outlook article.
3 Tobacco Stocks Worth Watching Amid Industry Challenges
by Vrishali Bagree
The Zacks Tobacco industry companies have been grappling with soft cigarette volume and elevated cost hurdles. However, pricing power and strength in smoke-free products work well for Philip Morris (PM), Altria Group (MO) and British American Tobacco (BTI).
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPHD
Is Trending Stock Altria Group, Inc. (MO) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD
Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Has Altria Group (MO) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Altria (MO) and Procter & Gamble (PG) have performed compared to their sector so far this year.
Altria's (MO) Q1 Earnings Miss Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Altria's (MO) first-quarter 2024 results reflect lower cigarette shipment volumes as a result of macroeconomic pressure on ATC behavior. However, pricing remains an upside.
Compared to Estimates, Altria (MO) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Altria (MO) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Altria (MO) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of -0.86% and 0.03%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Altria (MO) Ahead of Q1 Earnings Release?
by Zacks Equity Research
Despite facing several challenges, we maintain our belief in Altria's (MO) strong fundamentals and its potential for growth.
Altria (MO) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $42.09, marking a +1.91% move from the previous day.
Helen of Troy (HELE) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Helen of Troy's (HELE) fourth-quarter performance is likely to reflect the adverse impact of pressured consumer spending. Persistent inflationary headwinds are a concern.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Altria (MO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kimberly-Clark (KMB) Q1 Earnings Coming Up: Is a Beat Likely?
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter results are likely to reflect manufacturing cost inflation and volume concerns in some markets, while brand strength and the FORCE program are likely to have aided.
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria (MO) Stock Moves -0.24%: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Altria (MO) stood at $40.95, denoting a -0.24% change from the preceding trading day.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Top Research Reports for ServiceNow, Progressive & Analog Devices
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including ServiceNow, Inc. (NOW), The Progressive Corporation (PGR) and Analog Devices, Inc. (ADI).
Altria's (MO) Smoke-Free Strength Helps Navigate Challenges
by Zacks Equity Research
Altria (MO) benefits from its focus on smoke-free product expansion and pricing power amid low cigarette volumes.
Altria (MO) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Altria (MO) closed at $41.96 in the latest trading session, marking a +0.74% move from the prior day.
Beer Business to Aid Constellation Brands (STZ) in Q4 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q4 results are expected to reflect gains from strong beer business trends as well as growth of Power Brands.
Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.